NL6806044A - - Google Patents

Info

Publication number
NL6806044A
NL6806044A NL6806044A NL6806044A NL6806044A NL 6806044 A NL6806044 A NL 6806044A NL 6806044 A NL6806044 A NL 6806044A NL 6806044 A NL6806044 A NL 6806044A NL 6806044 A NL6806044 A NL 6806044A
Authority
NL
Netherlands
Application number
NL6806044A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6806044A publication Critical patent/NL6806044A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NL6806044A 1967-08-10 1968-04-29 NL6806044A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65960667A 1967-08-10 1967-08-10

Publications (1)

Publication Number Publication Date
NL6806044A true NL6806044A (de) 1969-02-12

Family

ID=24646046

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6806044A NL6806044A (de) 1967-08-10 1968-04-29

Country Status (9)

Country Link
US (1) US3642816A (de)
JP (3) JPS509797B1 (de)
BE (1) BE714439A (de)
CH (1) CH507945A (de)
DE (1) DE1770303A1 (de)
FR (1) FR7693M (de)
GB (1) GB1225664A (de)
NL (1) NL6806044A (de)
SE (1) SE355018B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068523A1 (de) * 1969-08-28 1971-08-27 Pfizer

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224335A (en) * 1967-08-10 1980-09-23 Sterling Drug Inc. Tetrahydrocarbazoles and their use
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3920694A (en) * 1974-06-03 1975-11-18 Warner Lambert Co 4-hydroxy-9-methyl-4-vinyl-1,2,3,4-tetrahydrocarbazole
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments
EP0603432B1 (de) * 1992-12-18 1998-10-21 Smithkline Beecham Plc Tetrahydrocarbazol-Derivate zur Herstellung eines Arzneimittels für die Behandlung von Krankheiten, wo ein 5-HT1-Agonist angezeigt ist
DE69610793T2 (de) * 1995-06-23 2001-05-03 Lilly Co Eli 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068523A1 (de) * 1969-08-28 1971-08-27 Pfizer

Also Published As

Publication number Publication date
CH507945A (de) 1971-05-31
JPS5235669B1 (de) 1977-09-10
GB1225664A (de) 1971-03-17
JPS5328915B1 (de) 1978-08-17
US3642816A (en) 1972-02-15
JPS509797B1 (de) 1975-04-16
BE714439A (de) 1968-10-30
SE355018B (de) 1973-04-02
FR7693M (de) 1970-02-23
DE1770303A1 (de) 1971-10-07

Similar Documents

Publication Publication Date Title
AU425114B2 (de)
JPS5235669B1 (de)
AU416737B2 (de)
AU2277767A (de)
AU342066A (de)
AU2256867A (de)
AU610966A (de)
AU2454867A (de)
AU3151267A (de)
AU2116667A (de)
AU2528767A (de)
AU2977667A (de)
AU3189468A (de)
AU97666A (de)
BE609869A (de)
AU25066A (de)
AU34866A (de)
AU408412B2 (de)
AU2406369A (de)
AU1868267A (de)
AU459699A (de)
AU1763766A (de)
AU1677166A (de)
BE692375A (de)
BE162295A (de)